A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder
Article in Psychiatry Research (February 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Psychiatry Research (February 2024)
Article in Scientific Reports (July 2023)
Article in Nature Communications (July 2023)